世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

動物用卵胞刺激ホルモン（FSH）の世界市場インサイト、2029年までの予測


Global Veterinary Follicle Stimulating Hormones (FSH) Market Insights, Forecast to 2029

動物用卵胞刺激ホルモン（FSH）の世界市場は、2023年の100万米ドルから2029年には100万米ドルに達すると予測され、予測期間中の年間平均成長率（CAGR）は %と予測されます。 獣医用卵胞刺激ホルモン（FSH）の米... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2023年5月2日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

動物用卵胞刺激ホルモン（FSH）の世界市場は、2023年の100万米ドルから2029年には100万米ドルに達すると予測され、予測期間中の年間平均成長率（CAGR）は %と予測されます。
獣医用卵胞刺激ホルモン（FSH）の米国・カナダ市場は、2023年の100万ドルから2029年には100万ドルに達すると予測され、2023年から2029年の予測期間中にCAGR %で増加する。
動物用卵胞刺激ホルモン（FSH）の中国市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中にCAGR %で増加するとされています。
動物用卵胞刺激ホルモン（FSH）の欧州市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中に年平均成長率（CAGR）％で増加すると予測されています。
動物用卵胞刺激ホルモン（FSH）の世界の主要メーカーは、Trophogen, Inc、Vetoquinol、Calier、MSD、Laboratorios HIPRA, S.A.、Ningbo Second Hormone Factory、SUMUなど。2022年、世界の上位5社は、売上高で約 %のシェアを占めています。

レポートには、以下の内容が含まれています：
本レポートでは、動物用卵胞刺激ホルモン（FSH）の世界市場の概要、売上、収益、価格などを紹介しています。2018年～2022年の歴史的な市場収益/販売データ、2023年の予測、2029年までのCAGRの予測により、世界市場動向を分析します。
本レポートでは、動物用卵胞刺激ホルモン（FSH）の主要生産者を調査し、主要地域や国の売上も掲載しています。動物用卵胞刺激ホルモン（FSH）の今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国に焦点を当てます。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他諸国の国別データおよび市場価値分析。

本レポートでは、2018年から2023年のデータをもとに、動物用卵胞刺激ホルモン（FSH）の売上、収益、主要メーカーの市場シェア、業界ランキングに焦点を当てています。世界の動物用卵胞刺激ホルモン（FSH）市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づき分析します。本レポートは、関係者が競争環境を理解し、より多くの洞察を得て、事業と市場戦略をより良い方法で位置づけるのに役立ちます。
本レポートでは、2018年から2029年までの、タイプ別、用途別のセグメントデータ、売上、収益、価格を分析しています。動物用卵胞刺激ホルモン（FSH）の売上高、予測される成長動向、生産技術、用途、エンドユーザー産業の評価と市場規模を予測します。
Trophogen, Inc、Vetoquinol、Calier、MSD、Laboratorios HIPRA, S.A.、Ningbo Second Hormone Factory、SUMUなど、世界の主要プレイヤーの記述的会社プロファイル。

会社別
トロフォゲン社
ベトキノール
カリエ
さいだいゆうこうすうじ
ラボラトリオス・ヒプラ社（Laboratorios HIPRA, S.A.
寧波第二ホルモン工場
スム
タイプ別セグメント
血清ゴナドトロフィンと絨毛性ゴナドトロフィン
絨毛性ゴナドトロフィン
フォルトロピン
その他
用途別セグメント
ウシ
シープ
馬
その他
地域別セグメント
アメリカ・カナダ
U.S.
カナダ
中国
アジア（中国を除く）
日本
南朝鮮
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中近東、アフリカ、中南米
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

章立て
第1章：報告書のスコープ、市場セグメント別（タイプ別、用途別など）のエグゼクティブサマリー、各市場セグメントの市場規模、将来の発展可能性などを紹介。市場の現状と、短中期および長期的にどのような進化を遂げる可能性があるのかについて、ハイレベルな視点で解説しています。
第2章 動物用卵胞刺激ホルモン（FSH）の世界、地域レベル、国レベルでの販売（消費）、収益。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来の発展見通し、市場スペース、生産能力などを紹介しています。
第3章：動物用卵胞刺激ホルモン（FSH）メーカーの競争環境、価格、販売、収益、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析します。
第4章：種類別に様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのを助けるために提供します。
第5章：読者が異なる下流市場でブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーする、様々な市場セグメントのアプリケーションの分析を提供します。
第6章：米国とカナダ（US & Canada）タイプ別、アプリケーション別、国別、各セグメント別の売上と収益。
第7章：ヨーロッパ（Europe）タイプ別、アプリケーション別、国別、セグメント別の売上と収益。
第8章：中国 種類別、用途別、国別、各セグメント別の売上と収益。
第9章：アジア（中国を除く） タイプ別、アプリケーション別、地域別、各セグメント別の売上と収益。
第10章：中東、アフリカ、中南米：タイプ別、アプリケーション別、国別、各セグメント別の売上と収益。
第11章：主要メーカーのプロフィールを提供し、製品の説明や仕様、動物用卵胞刺激ホルモン（FSH）の売上、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本状況を詳細に紹介する。
第12章：産業チェーン、販売チャネル、主要原材料、流通業者、顧客に関する分析。
第13章：市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析などを紹介します。
第14章：本レポートの要点と結論。


ページTOPに戻る


目次

1 Study Coverage
1.1 Veterinary Follicle Stimulating Hormones (FSH) Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Serum Gonadotrophin and Chorionic Gonadotrophin
1.2.3 Chorionic Gonadotrophin
1.2.4 Folltropin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Bovine
1.3.3 Sheep
1.3.4 Horse
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Estimates and Forecasts 2018-2029
2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region
2.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region (2018-2023)
2.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region (2024-2029)
2.2.4 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Region (2018-2029)
2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Estimates and Forecasts 2018-2029
2.4 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region
2.4.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2018-2023)
2.4.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2024-2029)
2.4.4 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Manufacturers
3.1.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Manufacturers (2018-2023)
3.1.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Follicle Stimulating Hormones (FSH) in 2022
3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Manufacturers
3.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Manufacturers (2018-2023)
3.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Veterinary Follicle Stimulating Hormones (FSH) Revenue in 2022
3.3 Global Key Players of Veterinary Follicle Stimulating Hormones (FSH), Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Veterinary Follicle Stimulating Hormones (FSH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Veterinary Follicle Stimulating Hormones (FSH), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Veterinary Follicle Stimulating Hormones (FSH), Product Offered and Application
3.8 Global Key Manufacturers of Veterinary Follicle Stimulating Hormones (FSH), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type
4.1.1 Global Veterinary Follicle Stimulating Hormones (FSH) Historical Sales by Type (2018-2023)
4.1.2 Global Veterinary Follicle Stimulating Hormones (FSH) Forecasted Sales by Type (2024-2029)
4.1.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Type (2018-2029)
4.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type
4.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Historical Revenue by Type (2018-2023)
4.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Type (2018-2029)
4.3 Global Veterinary Follicle Stimulating Hormones (FSH) Price by Type
4.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Price by Type (2018-2023)
4.3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application
5.1.1 Global Veterinary Follicle Stimulating Hormones (FSH) Historical Sales by Application (2018-2023)
5.1.2 Global Veterinary Follicle Stimulating Hormones (FSH) Forecasted Sales by Application (2024-2029)
5.1.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Application (2018-2029)
5.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application
5.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Historical Revenue by Application (2018-2023)
5.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Application (2018-2029)
5.3 Global Veterinary Follicle Stimulating Hormones (FSH) Price by Application
5.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Price by Application (2018-2023)
5.3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Market Size by Type
6.1.1 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2018-2029)
6.1.2 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2018-2029)
6.2 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Market Size by Application
6.2.1 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2018-2029)
6.2.2 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2018-2029)
6.3 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Market Size by Country
6.3.1 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2018-2029)
6.3.3 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Market Size by Type
7.1.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2018-2029)
7.1.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2018-2029)
7.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Market Size by Application
7.2.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2018-2029)
7.2.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2018-2029)
7.3 Europe Veterinary Follicle Stimulating Hormones (FSH) Market Size by Country
7.3.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2018-2029)
7.3.3 Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Veterinary Follicle Stimulating Hormones (FSH) Market Size
8.1.1 China Veterinary Follicle Stimulating Hormones (FSH) Sales (2018-2029)
8.1.2 China Veterinary Follicle Stimulating Hormones (FSH) Revenue (2018-2029)
8.2 China Veterinary Follicle Stimulating Hormones (FSH) Market Size by Application
8.2.1 China Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2018-2029)
8.2.2 China Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Veterinary Follicle Stimulating Hormones (FSH) Market Size by Type
9.1.1 Asia Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2018-2029)
9.1.2 Asia Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2018-2029)
9.2 Asia Veterinary Follicle Stimulating Hormones (FSH) Market Size by Application
9.2.1 Asia Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2018-2029)
9.2.2 Asia Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2018-2029)
9.3 Asia Veterinary Follicle Stimulating Hormones (FSH) Sales by Region
9.3.1 Asia Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region (2018-2029)
9.3.3 Asia Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Market Size by Type
10.1.1 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Market Size by Application
10.2.1 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Sales by Country
10.3.1 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Trophogen, Inc
11.1.1 Trophogen, Inc Company Information
11.1.2 Trophogen, Inc Overview
11.1.3 Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Trophogen, Inc Recent Developments
11.2 Vetoquinol
11.2.1 Vetoquinol Company Information
11.2.2 Vetoquinol Overview
11.2.3 Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vetoquinol Recent Developments
11.3 Calier
11.3.1 Calier Company Information
11.3.2 Calier Overview
11.3.3 Calier Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Calier Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Calier Recent Developments
11.4 MSD
11.4.1 MSD Company Information
11.4.2 MSD Overview
11.4.3 MSD Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 MSD Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MSD Recent Developments
11.5 Laboratorios HIPRA, S.A.
11.5.1 Laboratorios HIPRA, S.A. Company Information
11.5.2 Laboratorios HIPRA, S.A. Overview
11.5.3 Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Laboratorios HIPRA, S.A. Recent Developments
11.6 Ningbo Second Hormone Factory
11.6.1 Ningbo Second Hormone Factory Company Information
11.6.2 Ningbo Second Hormone Factory Overview
11.6.3 Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ningbo Second Hormone Factory Recent Developments
11.7 SUMU
11.7.1 SUMU Company Information
11.7.2 SUMU Overview
11.7.3 SUMU Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 SUMU Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 SUMU Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Veterinary Follicle Stimulating Hormones (FSH) Industry Chain Analysis
12.2 Veterinary Follicle Stimulating Hormones (FSH) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Veterinary Follicle Stimulating Hormones (FSH) Production Mode & Process
12.4 Veterinary Follicle Stimulating Hormones (FSH) Sales and Marketing
12.4.1 Veterinary Follicle Stimulating Hormones (FSH) Sales Channels
12.4.2 Veterinary Follicle Stimulating Hormones (FSH) Distributors
12.5 Veterinary Follicle Stimulating Hormones (FSH) Customers
13 Market Dynamics
13.1 Veterinary Follicle Stimulating Hormones (FSH) Industry Trends
13.2 Veterinary Follicle Stimulating Hormones (FSH) Market Drivers
13.3 Veterinary Follicle Stimulating Hormones (FSH) Market Challenges
13.4 Veterinary Follicle Stimulating Hormones (FSH) Market Restraints
14 Key Findings in The Global Veterinary Follicle Stimulating Hormones (FSH) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る


　

Summary

The global Veterinary Follicle Stimulating Hormones (FSH) market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Veterinary Follicle Stimulating Hormones (FSH) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Veterinary Follicle Stimulating Hormones (FSH) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Veterinary Follicle Stimulating Hormones (FSH) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Veterinary Follicle Stimulating Hormones (FSH) include Trophogen, Inc, Vetoquinol, Calier, MSD, Laboratorios HIPRA, S.A., Ningbo Second Hormone Factory and SUMU, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:
This report presents an overview of global market for Veterinary Follicle Stimulating Hormones (FSH), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Veterinary Follicle Stimulating Hormones (FSH), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Veterinary Follicle Stimulating Hormones (FSH), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Follicle Stimulating Hormones (FSH) sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Veterinary Follicle Stimulating Hormones (FSH) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Veterinary Follicle Stimulating Hormones (FSH) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Trophogen, Inc, Vetoquinol, Calier, MSD, Laboratorios HIPRA, S.A., Ningbo Second Hormone Factory and SUMU, etc.

By Company
Trophogen, Inc
Vetoquinol
Calier
MSD
Laboratorios HIPRA, S.A.
Ningbo Second Hormone Factory
SUMU
Segment by Type
Serum Gonadotrophin and Chorionic Gonadotrophin
Chorionic Gonadotrophin
Folltropin
Others
Segment by Application
Bovine
Sheep
Horse
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Veterinary Follicle Stimulating Hormones (FSH) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Veterinary Follicle Stimulating Hormones (FSH) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Follicle Stimulating Hormones (FSH) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Veterinary Follicle Stimulating Hormones (FSH) Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Serum Gonadotrophin and Chorionic Gonadotrophin
1.2.3 Chorionic Gonadotrophin
1.2.4 Folltropin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Bovine
1.3.3 Sheep
1.3.4 Horse
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Estimates and Forecasts 2018-2029
2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region
2.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region (2018-2023)
2.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region (2024-2029)
2.2.4 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Region (2018-2029)
2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Estimates and Forecasts 2018-2029
2.4 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region
2.4.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2018-2023)
2.4.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2024-2029)
2.4.4 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Manufacturers
3.1.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Manufacturers (2018-2023)
3.1.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Follicle Stimulating Hormones (FSH) in 2022
3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Manufacturers
3.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Manufacturers (2018-2023)
3.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Veterinary Follicle Stimulating Hormones (FSH) Revenue in 2022
3.3 Global Key Players of Veterinary Follicle Stimulating Hormones (FSH), Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Veterinary Follicle Stimulating Hormones (FSH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Veterinary Follicle Stimulating Hormones (FSH), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Veterinary Follicle Stimulating Hormones (FSH), Product Offered and Application
3.8 Global Key Manufacturers of Veterinary Follicle Stimulating Hormones (FSH), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type
4.1.1 Global Veterinary Follicle Stimulating Hormones (FSH) Historical Sales by Type (2018-2023)
4.1.2 Global Veterinary Follicle Stimulating Hormones (FSH) Forecasted Sales by Type (2024-2029)
4.1.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Type (2018-2029)
4.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type
4.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Historical Revenue by Type (2018-2023)
4.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Type (2018-2029)
4.3 Global Veterinary Follicle Stimulating Hormones (FSH) Price by Type
4.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Price by Type (2018-2023)
4.3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application
5.1.1 Global Veterinary Follicle Stimulating Hormones (FSH) Historical Sales by Application (2018-2023)
5.1.2 Global Veterinary Follicle Stimulating Hormones (FSH) Forecasted Sales by Application (2024-2029)
5.1.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Application (2018-2029)
5.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application
5.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Historical Revenue by Application (2018-2023)
5.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Application (2018-2029)
5.3 Global Veterinary Follicle Stimulating Hormones (FSH) Price by Application
5.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Price by Application (2018-2023)
5.3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Market Size by Type
6.1.1 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2018-2029)
6.1.2 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2018-2029)
6.2 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Market Size by Application
6.2.1 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2018-2029)
6.2.2 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2018-2029)
6.3 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Market Size by Country
6.3.1 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2018-2029)
6.3.3 US & Canada Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Market Size by Type
7.1.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2018-2029)
7.1.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2018-2029)
7.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Market Size by Application
7.2.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2018-2029)
7.2.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2018-2029)
7.3 Europe Veterinary Follicle Stimulating Hormones (FSH) Market Size by Country
7.3.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2018-2029)
7.3.3 Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Veterinary Follicle Stimulating Hormones (FSH) Market Size
8.1.1 China Veterinary Follicle Stimulating Hormones (FSH) Sales (2018-2029)
8.1.2 China Veterinary Follicle Stimulating Hormones (FSH) Revenue (2018-2029)
8.2 China Veterinary Follicle Stimulating Hormones (FSH) Market Size by Application
8.2.1 China Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2018-2029)
8.2.2 China Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Veterinary Follicle Stimulating Hormones (FSH) Market Size by Type
9.1.1 Asia Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2018-2029)
9.1.2 Asia Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2018-2029)
9.2 Asia Veterinary Follicle Stimulating Hormones (FSH) Market Size by Application
9.2.1 Asia Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2018-2029)
9.2.2 Asia Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2018-2029)
9.3 Asia Veterinary Follicle Stimulating Hormones (FSH) Sales by Region
9.3.1 Asia Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region (2018-2029)
9.3.3 Asia Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Market Size by Type
10.1.1 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Market Size by Application
10.2.1 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Sales by Country
10.3.1 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Trophogen, Inc
11.1.1 Trophogen, Inc Company Information
11.1.2 Trophogen, Inc Overview
11.1.3 Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Trophogen, Inc Recent Developments
11.2 Vetoquinol
11.2.1 Vetoquinol Company Information
11.2.2 Vetoquinol Overview
11.2.3 Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vetoquinol Recent Developments
11.3 Calier
11.3.1 Calier Company Information
11.3.2 Calier Overview
11.3.3 Calier Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Calier Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Calier Recent Developments
11.4 MSD
11.4.1 MSD Company Information
11.4.2 MSD Overview
11.4.3 MSD Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 MSD Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MSD Recent Developments
11.5 Laboratorios HIPRA, S.A.
11.5.1 Laboratorios HIPRA, S.A. Company Information
11.5.2 Laboratorios HIPRA, S.A. Overview
11.5.3 Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Laboratorios HIPRA, S.A. Recent Developments
11.6 Ningbo Second Hormone Factory
11.6.1 Ningbo Second Hormone Factory Company Information
11.6.2 Ningbo Second Hormone Factory Overview
11.6.3 Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ningbo Second Hormone Factory Recent Developments
11.7 SUMU
11.7.1 SUMU Company Information
11.7.2 SUMU Overview
11.7.3 SUMU Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 SUMU Veterinary Follicle Stimulating Hormones (FSH) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 SUMU Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Veterinary Follicle Stimulating Hormones (FSH) Industry Chain Analysis
12.2 Veterinary Follicle Stimulating Hormones (FSH) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Veterinary Follicle Stimulating Hormones (FSH) Production Mode & Process
12.4 Veterinary Follicle Stimulating Hormones (FSH) Sales and Marketing
12.4.1 Veterinary Follicle Stimulating Hormones (FSH) Sales Channels
12.4.2 Veterinary Follicle Stimulating Hormones (FSH) Distributors
12.5 Veterinary Follicle Stimulating Hormones (FSH) Customers
13 Market Dynamics
13.1 Veterinary Follicle Stimulating Hormones (FSH) Industry Trends
13.2 Veterinary Follicle Stimulating Hormones (FSH) Market Drivers
13.3 Veterinary Follicle Stimulating Hormones (FSH) Market Challenges
13.4 Veterinary Follicle Stimulating Hormones (FSH) Market Restraints
14 Key Findings in The Global Veterinary Follicle Stimulating Hormones (FSH) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

QYResearch社の医薬・ヘルスケア分野での最新刊レポート

本レポートと同じKEY WORD（veterinary）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15　10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.